Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 688 | 683 | 702 | 688 | -27 |
| Accounts receivable | -5,600 | -5,397 | -3,231 | -1,187 | 109 |
| Accounts payable and accrued liabilities | N/A | 118 | 8,134 | -7,103 | N/A |
| Other Working Capital | -1,763 | -11,679 | 1,369 | -9,560 | -101 |
| Other Operating Activity | -19,247 | -23,975 | -44,953 | -36,379 | 5,476 |
| Operating Cash Flow | $-25,922 | $-40,250 | $-37,979 | $-53,541 | $5,457 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | 96 | -222 | -136 | -3,753 |
| Purchase Of Investment | -96,127 | -125,844 | -101,819 | -115,168 | 0 |
| Sale Of Investment | 90,675 | 99,101 | 103,711 | 60,940 | 21,362 |
| Purchase Sale Intangibles | 0 | -159 | 0 | -1,039 | N/A |
| Other Investing Activity | 0 | -6,000 | 0 | -11,844 | -716 |
| Investing Cash Flow | $-5,487 | $-32,806 | $1,670 | $-67,247 | $16,893 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 196,740 | N/A | N/A | N/A | 0 |
| Other Financing Activity | 8,982 | 9,082 | 1,279 | 5,029 | 1,242 |
| Financing Cash Flow | $205,722 | $9,082 | $1,279 | $5,029 | $1,242 |
| Beginning Cash Position | 57,587 | 121,561 | 156,591 | 272,350 | 248,758 |
| End Cash Position | 231,900 | 57,587 | 121,561 | 156,591 | 272,350 |
| Net Cash Flow | $174,313 | $-63,974 | $-35,030 | $-115,759 | $23,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,922 | -40,250 | -37,979 | -53,541 | 5,457 |
| Capital Expenditure | -35 | -63 | -222 | -1,181 | -4,469 |
| Free Cash Flow | -25,957 | -40,313 | -38,201 | -54,722 | 988 |